https://www.ckptherapeutics.com/news/new-path-found-to-treat-'cancer'-patients-who-don't-respond-to-anticancer-drugs 2023-04-12 https://www.ckptherapeutics.com/news/global-m%26a%2C-an-'opportunity'-for-domestic-companies...-which-biotech-startups-are-attracting-attention%3F 2023-04-12 https://www.ckptherapeutics.com/news/development-of-'leading-substance'-to-inhibit-the-growth-of-cancer-cells-that-do-not-respond-to-anticancer-drugs 2023-04-12 https://www.ckptherapeutics.com/news/hope-for-cancer-without-anticancer-drugs...-domestic-research-team-develops-new-drug-candidates 2023-04-12 https://www.ckptherapeutics.com/news/-ckp-therapeutics%2C-%E2%80%9Cdevelopment-of-intractable-cancer-drug-candidates-by-killing-cancer-stem-cells%E2%80%9D 2023-04-12 https://www.ckptherapeutics.com/news/research-finds-stem-cell-focused-solution-to-treat-drug-resistant-cancers 2023-04-12 https://www.ckptherapeutics.com/news/ckp-therapeutics-first-to-propose-novel-treatment-applied-to-refractory-liver-cancer-using-serca-inhibitor 2023-04-12 https://www.ckptherapeutics.com/news/researchers-link-drug-resistance-to--cancer-stem-cell-survival 2023-04-12 https://www.ckptherapeutics.com/news/yonsei-researchers-find-novel-drug-candidate-to-treat-clinically-refractory-cancers 2023-04-12 https://www.ckptherapeutics.com/news/new-path-to-treat-drug-resistant-cancer-discovered 2023-04-12